2-naphthol has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, JX; Zhang, HY | 1 |
| Adachi, M; Bharadwaj, U; Chen, Y; Eckols, TK; Kasembeli, MM; Lai, SY; Mo, Q; Song, Y; Tweardy, DJ; Xu, X | 1 |
2 other study(ies) available for 2-naphthol and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Humans; Naphthols; Phosphorylation; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Sulfonamides; Tumor Cells, Cultured; Wound Healing | 2019 |
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Naphthols; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Sulfonamides; Xenograft Model Antitumor Assays | 2016 |